Hermosa Beach, CA, United States of America

Alan H Auerbach

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alan H Auerbach: Innovator in Cancer Treatment

Introduction

Alan H Auerbach is a notable inventor based in Hermosa Beach, California. He has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of two patents to his name, Auerbach's work focuses on advancing therapeutic options for cancer patients.

Latest Patents

Auerbach's latest patents detail methods and compositions for treating cancer. These methods involve administering a 17α-hydroxylase/C-lyase inhibitor, such as abiraterone acetate, in combination with at least one additional therapeutic agent, which may include an anti-cancer agent or a steroid. The compositions he has developed also incorporate a 17α-hydroxylase/C-lyase inhibitor alongside additional therapeutic agents to enhance treatment efficacy.

Career Highlights

Throughout his career, Auerbach has worked with prominent organizations, including Janssen Oncology, Inc. and British Technology Group Limited. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in oncology.

Collaborations

Some of Auerbach's notable coworkers include Arie S Belldegrun and Arie S Belldegrun. Their collaborative efforts have further advanced the research and development of cancer treatments.

Conclusion

Alan H Auerbach's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for improved therapeutic options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…